Skip to content
healthcare.dev

Guaifenesin

NDC 51660-567, Guaifenesin, tablet, extended release, from Ohm Laboratories, Inc..

Product NDC
51660-567
Status
Listed
Labeler
Ohm Laboratories, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209254
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51660-567 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
51660-567-545166005675414 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-54)
51660-567-585166005675856 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-58)
51660-567-865166005678628 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 51660056786

    GET /v1/drugs/nadac/51660056786

Use it

Look up 51660-567 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51660-567 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51660-567. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.